M&A

Alexion Pharma to Buy Portola for $18-Share, or $1.41 Billion
TheStreet.com
Tue, 05/5/20 - 11:08 am
Alexion
M&A
Portola Pharmaceuticals
AndexXa
Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M
Xconomy
Mon, 05/4/20 - 10:35 pm
Stemline Therapeutics
M&A
Menarini
AbbVie CEO: Don't worry, Allergan's aesthetics clients still have money—and 'strong desire' for treatment
Fierce Pharma
Fri, 05/1/20 - 12:57 pm
AbbVie
Allergan
M&A
aesthetics
pandemic
COVID-19
Amgen's anti-inflammatory Otezla makes its foray into COVID-19
Fierce Pharma
Fri, 05/1/20 - 12:47 pm
Amgen
Celgene
Otezla
M&A
COVID-19
Having sold its corporate self, Tocagen auctions off scientific platform to San Diego biotech
Endpoints
Thu, 04/30/20 - 10:47 am
Tocagen
Forte Biosciences
Denovo Biopharma
gene therapy
M&A
Abiomed stock up amid Street-beating Q4 profits, news of Breethe acquisition
Mass Device
Thu, 04/30/20 - 10:45 am
Abiomed
devices
earnings
M&A
Breethe
ECMO
COVID-19
pandemic
Novartis spinout resTORbio reverse merges with T cell biotech after big PhIII failure
Endpoints
Wed, 04/29/20 - 10:31 am
Novartis
ResTORbio
M&A
Parkinson's Disease
Adicet Bio
BioNTech plays down takeover talk ahead of COVID-19 vaccine trial
Pharmaforum
Mon, 04/27/20 - 07:30 pm
BioNTech
COVID-19
M&A
Pfizer
vaccines
7 Bold Predictions for Medtech After COVID-19
Medical Devices and Diagnostics Industry
Sun, 04/26/20 - 08:35 pm
devices
Medtech
COVID-19
elective procedures
diagnostics
clinical trials
M&A
telemedicine
Novartis eyes a new market with its buyout of a small digital therapeutics player
Endpoints
Mon, 04/20/20 - 10:51 am
Novartis
M&A
Amblyotech
digital therapeutics
lazy eye
Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Beckers Hospital Review
Thu, 04/16/20 - 11:07 am
Mylan
Robert Coury
Upjohn
generics
M&A
COVID-19
pandemic
Organovo Future Unclear After Shareholders Reject Tarveda Merger
Xconomy
Wed, 04/8/20 - 11:46 pm
Organovo
M&A
Tarveda Therapeutics
Biopharma acquisitions slow, but it's not Covid-19's fault yet
EP Vantage
Wed, 04/8/20 - 10:28 am
M&A
COVID-19
Gilead Sciences
Forty Seven
Eli Lilly
Dermira
Takeda
Hypera Pharma
ANI Pharmaceuticals
Amerigen Pharma
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
Mylan, Pfizer offer undisclosed concessions as part of EU merger review
Fierce Pharma
Tue, 03/31/20 - 10:00 pm
Mylan
Pfizer
Upjohn
Europe
M&A
Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic
Marketwatch
Mon, 03/30/20 - 10:30 am
COVID-19
pandemic
clinical trials
drug launches
M&A
conferences
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch
Xconomy
Thu, 03/26/20 - 10:42 am
Bristol-Meyers Squibb
Celgene
M&A
ozanimod
MS
mutliple sclerosis
drug launches
FDA
COVID-19
Zeposia
Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger
Fierce Pharma
Thu, 03/26/20 - 10:27 am
COVID-19
Pfizer
Mylan
Viatris
M&A
AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger
BioSpace
Thu, 03/19/20 - 12:01 am
AbbVie
Allergan
FTC
M&A
Bristol Myers CEO Caforio hires a top investment banker from Barclays for his next BD/strategy chief
Endpoints
Wed, 03/18/20 - 10:18 am
Bristol-Myers Squibb
M&A
Giovanni Caforio

Pages